ADIPOQ and malignant colon neoplasm: A series of studies by Saxena et al. demonstrated that adiponectin conferred protection against inflammation-induced colon cancers by preventing apoptosis in the goblet cells and promoting differentiation of epithelial cells to goblet cells [132,133].